In the market, there are also two CE-marked tests for the detection of cervical cancer (Cervi-M®) and oral cancer (Oral-M®) by analyzing PAX1 and ZNF582 gene methylation in cervix smears and oral epithelial cells [110,111]. This evidence concerns the gene PAX1 and cervical carcinoma.